Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial by Younes, Anas, Prof, Santoro, Armando, Prof, Shipp, Margaret, Prof, Zinzani, Pier Luigi, Prof, Timmerman, John M, MD, Ansell, Stephen, Prof, Armand, Philippe, MD, Fanale, Michelle, MD, Ratanatharathorn, Voravit, MD, Kuruvilla, John, MD, Cohen, Jonathon B, MD, Collins, Graham, MD, Savage, Kerry J, MD, Trneny, Marek, Prof, Kato, Kazunobu, MD, Farsaci, Benedetto, MD, Parker, Susan M, PhD, Rodig, Scott, MD, Roemer, Margaretha G M, MS, Ligon, Azra H, PhD, Engert, Andreas, Prof

Get full text

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial by Coiffier, Bertrand, Prof, Osmanov, Evgenii A, Prof, Hong, Xiaonan, Prof, Scheliga, Adriana, MD, Mayer, Jiri, Prof, Offner, Fritz, Prof, Rule, Simon, MD, Teixeira, Adriana, MD, Walewski, Jan, Prof, de Vos, Sven, MD, Crump, Michael, Prof, Shpilberg, Ofer, Prof, Esseltine, Dixie-Lee, MD, Zhu, Eugene, PhD, Enny, Christopher, BS, Theocharous, Panteli, PhD, van de Velde, Helgi, MD, Elsayed, Yusri A, MD, Zinzani, Pier Luigi, Prof

Get full text

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThe... by Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

Get full text

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial by Prince, H Miles, Prof, Kim, Youn H, Prof, Horwitz, Steven M, MD, Dummer, Reinhard, Prof, Scarisbrick, Julia, MD, Quaglino, Pietro, Prof, Zinzani, Pier Luigi, Prof, Wolter, Pascal, MD, Sanches, Jose A, PhD, Ortiz-Romero, Pablo L, Prof, Akilov, Oleg E, MD, Geskin, Larisa, MD, Trotman, Judith, MD, Taylor, Kerry, MBBS, Dalle, Stephane, Prof, Weichenthal, Michael, Prof, Walewski, Jan, Prof, Fisher, David, MD, Dréno, Brigitte, Prof, Stadler, Rudolf, Prof, Feldman, Tatyana, MD, Kuzel, Timothy M, Prof, Wang, Yinghui, MS, Palanca-Wessels, Maria Corinna, MD, Zagadailov, Erin, PharmD, Trepicchio, William L, PhD, Zhang, Wenwen, PhD, Lin, Hui-Min, PhD, Liu, Yi, PhD, Huebner, Dirk, MD, Little, Meredith, MPH, Whittaker, Sean, Prof, Duvic, Madeleine, Prof

Get full text

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without ri... by Pfreundschuh, Michael, Prof, Ho, Anthony D, MD, Cavallin-Stahl, Eva, MD, Wolf, Max, Prof, Pettengell, Ruth, Prof, Vasova, Ingrid, MD, Belch, Andrew, MD, Walewski, Jan, MD, Zinzani, Pier-Luigi, MD, Mingrone, Walter, MD, Kvaloy, Stein, MD, Shpilberg, Ofer, Prof, Jaeger, Ulrich, Prof, Hansen, Mads, Prof, Corrado, Claudia, MD, Scheliga, Adriana, MD, Loeffler, Markus, Prof, Kuhnt, Evelyn, Dipl Math

Get full text

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, mu... by Pettengell, Ruth, Dr, Coiffier, Bertrand, Prof, Narayanan, Geetha, Prof, de Mendoza, Fernando Hurtado, MD, Digumarti, Raghunadharao, MD, Gomez, Henry, MD, Zinzani, Pier Luigi, MD, Schiller, Gary, Prof, Rizzieri, David, MD, Boland, Giles, Prof, Cernohous, Paul, MS, Wang, Lixia, PhD, Kuepfer, Christine, MS, Gorbatchevsky, Igor, MD, Singer, Jack W, Prof

Get full text

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised tria... by Zinzani, Pier Luigi, Dr, Tani, Monica, MD, Pulsoni, Alessandro, MD, Gobbi, Marco, Prof, Perotti, Alessio, MD, De Luca, Stefano, MD, Fabbri, Alberto, MD, Zaccaria, Alfonso, MD, Voso, Maria Teresa, MD, Fattori, Pierpaolo, MD, Guardigni, Luciano, MD, Ronconi, Sonia, MD, Cabras, Maria Giuseppina, MD, Rigacci, Luigi, MD, De Renzo, Amalia, MD, Marchi, Enrica, MD, Stefoni, Vittorio, MD, Fina, Mariapaola, MD, Pellegrini, Cinzia, MD, Musuraca, Gerardo, MD, Derenzini, Enrico, MD, Pileri, Stefano, Prof, Fanti, Stefano, MD, Piccaluga, Pier Paolo, MD, Baccarani, Michele, Prof

Get full text